Form 4 holding
COO and ICEO and IP, 10%+ Owner
Immune Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 15,607,998
- Estimated value
- Report date
- 25 Jul 2022
- Price
- Ownership
- By Murphy Advisors, Inc.
Kelly O'Brien Wilson - COO and ICEO and IP, 10%+ Owner at Biostax Corp.
Insider Transactions and Holdings
- Entity type
- Individual
- Role
- COO and ICEO and IP, 10%+ Owner
- Issuer symbol
- IMUN
- Source filings
- Open source filing history
There are no Buy or Sell transactions made by Kelly O'Brien Wilson since 29 May 2025
Holdings reported by Kelly O'Brien Wilson for Biostax Corp.
Form 4 holding
COO and ICEO and IP, 10%+ Owner
Immune Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,696,947
- Estimated value
- Report date
- 25 Jul 2022
- Price
- Ownership
- By spouse
Form 4 holding
COO and ICEO and IP, 10%+ Owner
Immune Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 500
- Estimated value
- Report date
- 25 Jul 2022
- Price
- Ownership
- Direct
Transactions reported by Kelly O'Brien Wilson for Biostax Corp.
| Sym | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
An asterisk next to the price means the reported price is likely invalid.